ArticleMolecular therapy oncolytics2022

Chimeric anti-GPC3 sFv-CD3ε receptor-modified T cells with IL7 co-expression for the treatment of solid tumors.

Yansha Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.